UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN

University of Illinois Urbana-Champaign LogoCancer Center
at Illinois

GIVE

  • Home
  • About
    • History
    • Strategic Plan
    • Leadership and Staff
    • Advisory Committees
    • Cancer Center Research & Health Innovation Complex
    • Communications Office
    • Partnerships
    • Merch Store
  • Research
    • Cancer Engineering & Biological Systems Program
    • Cancer Technology & Data Science Program
    • BEAT Cancer Research Initiative
    • CCIL Grant Programs
    • Working Groups
    • Shared Resources
    • Funding Opportunities
    • Cancer Research Advocacy Group
      • CRAG Members
  • Our Researchers
    • Meet CCIL Members
    • Become a Member
    • Why I Study Cancer
  • Education
    • High School
    • Undergraduate
    • Graduate
    • Postdoctoral
    • Mentoring
    • Student Organization
  • News
    • Latest News
    • CCIL Digest
    • Innovation Insider
    • Media Contact
    • CCIL in the News
  • Giving
    • Ways to Give
    • Giving Stories
  • Contact
Wang Lab Develops ‘Drug Depot’: A Novel Technology for Prevention of Post-Surgical Triple-Negative Breast Cancer Recurrence

Wang Lab Develops ‘Drug Depot’: A Novel Technology for Prevention of Post-Surgical Triple-Negative Breast Cancer Recurrence

May 14, 2024 | Cancer Center News

Cancer Center at Illinois (CCIL) member Hua Wang, professor of materials science and engineering, published new research in Materials Today Bio demonstrating the development of a novel technology to prevent post-surgical recurrence of breast cancer, especially...
Hacking Cell Communication: Researchers Develop Promising Cancer Vaccine

Hacking Cell Communication: Researchers Develop Promising Cancer Vaccine

Dec 14, 2023 | Cancer Center News

Cancer Center at Illinois (CCIL) researcher Hua Wang and Ph.D. student Rimsha Bhatta Cancer Center at Illinois (CCIL) member Hua Wang published new research with promising developments for the future of personalized cancer therapeutics. In a Nature Communications...
ER-positive Breast Cancer Presents Differing Metabolic Signatures in African American, White Women

ER-positive Breast Cancer Presents Differing Metabolic Signatures in African American, White Women

Sep 13, 2023 | Cancer Center News

Cancer Center at Illinois (CCIL) researcher and Director of Education, Zeynep Madak-Erdogan. (Photo by L. Brian Stauffer) New research found the most common form of breast cancer presents differing metabolic signatures in the blood of African American women with...
Bringing Cells to Life…and to Minecraft: $30 Million NSF Grant to Support Whole-Cell Modeling at the Beckman Institute 

Bringing Cells to Life…and to Minecraft: $30 Million NSF Grant to Support Whole-Cell Modeling at the Beckman Institute 

Sep 7, 2023 | Cancer Center News

Principal investigators Martin Gruebele (left) and Zan Luthey-Schulten (Photo by Fred Zwicky, University of Illinois Urbana-Champaign) Researchers, policymakers, and Minecraft players can look forward to the Beckman Institute for Advanced Science and Technology’s...
Metabolic Glycan Labeling Approach Shows Promise for Improving Dendritic Cell Vaccines

Metabolic Glycan Labeling Approach Shows Promise for Improving Dendritic Cell Vaccines

Sep 6, 2023 | Cancer Center News

Cancer Center at Illinois (CCIL) researchers Joonsu Han and Hua Wang Cancer Center at Illinois (CCIL) member Hua Wang and his research group are passionate about developing novel – but simple – solutions to not only improve the efficacy of cancer immunotherapies, but...
Researchers Develop a ‘Sweet’ Strategy for Targeted Cancer Therapeutics through Unnatural Sugar Metabolic Labeling

Researchers Develop a ‘Sweet’ Strategy for Targeted Cancer Therapeutics through Unnatural Sugar Metabolic Labeling

Aug 28, 2023 | Cancer Center News

CCIL researchers Bo Yang and Hua Wang Cancer Center at Illinois (CCIL) researchers have demonstrated a novel two-step strategy to label and eradicate cancer stem-like cells (CSC) to improve cancer treatment prognosis. CSCs are small sub-populations of cancer cells...
A novel metabolic pathway inhibitor holds therapeutic potential for metastatic breast cancer patients

A novel metabolic pathway inhibitor holds therapeutic potential for metastatic breast cancer patients

Jun 15, 2023 | Cancer Center News

Cancer Center at Illinois Program Leader Zeynep Madak-Erdogan and Research Assistant Ayca Nazli Mogol Illinois researchers have identified a metabolic pathway inhibitor with reduced toxicity and improved efficacy of therapeutic regimens and outcomes for metastatic...
CCIL Scientists Targeting Minor Cannabinoids as Potential Cancer Therapeutics

CCIL Scientists Targeting Minor Cannabinoids as Potential Cancer Therapeutics

May 25, 2022 | Cancer Center News

Urbana, Ill. – Cannabis has long been used to alleviate pain, reduce anxiety, and treat inflammation, with the earliest records dating back to 2737 B.C. in China. Today, many cancer patients use cannabis to treat pain and chemotherapy-related symptoms such as nausea,...
Cancer Center at Illinois team finds treatment of liver metastases in breast cancer patients improved by low-carb diets

Cancer Center at Illinois team finds treatment of liver metastases in breast cancer patients improved by low-carb diets

Mar 8, 2022 | Cancer Center News

Image of Zeynep Madak-Erdogan Urbana, Ill. – A new study by Cancer Center at Illinois Education Program Leader, Zeynep Madak-Erdogan and her team, have found a new mechanism of endocrine resistance in breast cancers metastasized to the liver. The study, published in...
Professor Zeynep Madak-Erdogan joins CCIL’s education program leadership

Professor Zeynep Madak-Erdogan joins CCIL’s education program leadership

Dec 1, 2021 | Cancer Center News

Zeynep Madak-Erdogan Urbana, Ill. – The Cancer Center at Illinois (CCIL) is excited to announce that Zeynep Madak-Erdogan, associate professor of food science and health nutrition (FSHN), has been appointed a CCIL Program Leader. Focusing on education, she will join...
PFAS exposure, high-fat diet drive prostate cells’ metabolism into pro-cancer state

PFAS exposure, high-fat diet drive prostate cells’ metabolism into pro-cancer state

Nov 16, 2021 | Cancer Center News

A new study in mice suggests that consuming a high-fat diet in combination with exposure to PFAS triggers changes in benign and malignant prostate cells that promote rapid tumor growth. Food science and human nutrition professor Zeynep Madak-Erdogan, center, led the...
Cholesterol Metabolite Induces Production of Cancer-Promoting Vesicles

Cholesterol Metabolite Induces Production of Cancer-Promoting Vesicles

Jun 16, 2021 | Cancer Center News

Erik Nelson Urbana, Ill. – Scientists working to understand the cellular processes linking high cholesterol to breast cancer recurrence and metastasis report that a byproduct of cholesterol metabolism causes some cells to send out cancer-promoting signals to other...
« Older Entries

Recent Posts

  • Illinois Professors Viktor Gruev and Shuming Nie Shed Light on the Future of True Color Imaging
  • Emerging Cancer Engineering Field Garners National Attention in Recent Workshop
  • Flightpath Biosciences Licenses Microbiome-Sparing Antibiotic Developed at Illinois
  • Sharps Lead the Endowment of the Directorship of the Cancer Center at Illinois
  • Manipulation of Light at the Nanoscale Helps Advance Biosensing

Archives

  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • October 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • August 2017
  • June 2017
  • May 2017
  • December 2016
  • July 2016

Categories

  • Administration
  • Cancer Center News
  • Cancer Scholars Program
  • CCIL Ambassadors
  • CCIL Shared Resources
  • Honors and Awards
  • Member Spotlight
  • Student Spotlight
  • TiMe Program
Cancer Center at Illinois University of Illinois Urbana-Champaign

405 N. Mathews Ave.
Urbana, IL 61801-2325 (M/C 251)
Email: cancercenter@illinois.edu
Phone: 217-300-6100

©2025 University of Illinois Board of Trustees

Designed by Clanin Creative | Solution By UniSyn

Facebook   Instagram   LinkedIn   X   Bluesky   Threads